Scientific article
English

Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets?

Contributors

Ruiz Altaba, Ariel

Published in

Cancer cell, vol. 14, no. 4, p. 281-283

Publication date

2008

Abstract

Hedgehog (HH)-GLI signaling is a developmental patterning pathway used by many tumors for bulk proliferation that has been shown also to regulate cancer stem cell self-renewal and survival. Surprisingly, a recent study by Yauch et al. (2008) proposes that HH-GLI signaling acts only on the tumor stroma. The mode of action of HH-GLI signaling in cancer may shape the development of therapeutic antagonists.

Keywords

  • Animals
  • Antineoplastic Agents/pharmacology
  • Cell Proliferation/drug effects
  • Cell Survival/drug effects
  • Epithelial Cells/drug effects/metabolism
  • Hedgehog Proteins/metabolism
  • Humans
  • Neoplasms/drug therapy/metabolism/pathology
  • Neoplastic Stem Cells/drug effects/metabolism
  • Paracrine Communication/drug effects
  • Receptors, G-Protein-Coupled/antagonists & inhibitors/metabolism
  • Signal Transduction/drug effects
  • Stromal Cells/drug effects/metabolism
  • Transcription Factors/metabolism

Citation (ISO format)

RUIZ ALTABA, Ariel. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets? In: Cancer cell, 2008, vol. 14, n° 4, p. 281–283. doi: 10.1016/j.ccr.2008.09.007

Main files (1)

Article (Accepted version)

Identifiers

Journal ISSN

1535-6108
640views
2downloads

Technical informations

Creation

06/04/2009 09:00:00

First validation

06/04/2009 09:00:00

Update

14/03/2023 15:04:30

Status update

14/03/2023 15:04:30

Last indexation

29/10/2024 11:28:46
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated